Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.

Saved in:
Bibliographic Details
Title: Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.
Authors: Packard CJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Taskinen MR; Research Programs Unit, Clinical and Molecular Medicine, University of Helsinki, Helsinki, Finland., Björnson E; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden., Matikainen N; Research Programs Unit, Clinical and Molecular Medicine, University of Helsinki, Helsinki, Finland; Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland., Söderlund S; Research Programs Unit, Clinical and Molecular Medicine, University of Helsinki, Helsinki, Finland; Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland., Andersson L; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden., Adiels M; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden., Borén J; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden; Wallenberg Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: jan.boren@wlab.gu.se.
Source: Atherosclerosis [Atherosclerosis] 2025 May; Vol. 404, pp. 119166. Date of Electronic Publication: 2025 Apr 05.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first